StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 03/25/2013 -- StockRunway.com issues special report on the Biotech Stocks on the Rise – Halozyme Therapeutics, Inc. (NASDAQ:HALO), Anacor Pharmaceuticals Inc (NASDAQ:ANAC), Inovio Pharmaceuticals Inc (NYSEAMEX:INO)
Halozyme Therapeutics, Inc. (NASDAQ:HALO) skyrocketed after the company and Baxter International Inc. declared that they have been provided a Positive Opinion to Baxter for the use of HyQvia as replacement therapy for adult patients with primary and secondary immunodeficiencies by the European Medicines Agency&aposs Committee for Medicinal Products for Human Use.
Halozyme Therapeutics, Inc.(NASDAQ:HALO) moved up +30.93% and closed at $6.90 with the total traded volume of 7.65 million shares. Its opening price was $6.13 and its shares traded within the range of $5.89-$6.98.
For How Long HALO will Fight for Profitability? Read This Trend Analysis report
This company has earnings per share of -$0.48 with the net profit margin of -126.53% and operating margin of -126.70%. The company now has market cap of about $780.53million.
Anacor Pharmaceuticals Inc (NASDAQ:ANAC) rallied on Friday after Wedbush lifted its price target on the stock to $20 from $10, following positive results from a Phase 2 dose-ranging trial of its topical boron-based phosphodiesterase-4 inhibitor, AN2728 on Thursday.
Anacor Pharmaceuticals Inc(NASDAQ:ANAC) gained +25.62% with the closing price of $6.08. The overall volume in the last trading session was 7.45 million shares. Its fifty two week range was $3.00-$7.18. The total market capitalization remained $216.26million.
For How Long ANAC’s Gloss will Attract Investors? Find out via this report
The stock is ahead its 52 week low with 102.67% and its last month price volatility remained 8.18% with a target price of $13.00. In its share capital, the company has 36.06 million outstanding shares while 32.48 million shares have been floated in market.
It has insider ownership of 0.27% with institutional ownership remained 81.38%. Earnings per share this year grew 37.16%.
Inovio Pharmaceuticals Inc (NYSEAMEX:INO) trended higher, one day after a Seeking Alpha post suggested that the stock offers great potential for near-term rebound.
Inovio Pharmaceuticals Inc(NYSEAMEX:INO) advanced +8.60% and closed at $0.580 in the last trading session with the overall traded volume of 2.29 million shares, more versus the average volume of 1.68 million shares. Its 52 weeks high price was $0.83 and suffered lowest price of $0.38 in the same period.
Will INO Continue To Move Higher? Find Out Here
INO has current ratio of 1.91. It has market cap of $104.35million while its total outstanding shares are 179.92million. The stock beta value stands at 2.75 times.
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you&aposre new to penny stocks or a seasoned veteran, you&aposll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway&aposs service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
For more information on this press release visit: http://www.sbwire.com/press-releases/biotech-stocks-on-the-rise-halozyme-therapeutics-halo-anacor-pharmaceuticals-anac-inovio-pharmaceuticals-ino-228261.htm